Media Report
News Release
News
2018-05-18
Asieris Announced Follow-on Investment to its B Round Funding
2018-05-07
Asieris Announced Appointment of Dr. Yijun Deng as VP of New Drug Discovery
2018-04-24
Notice of Relocation of Our Shanghai Office
2018-04-08
Asieris Pharmaceuticals Invited to be a Panelist at the APRDL 2018
2017-12-27
Asieris Announced Closing of Series B Funding Round in Excess of 100 Million RMB
2017-08-26
Asieris Pharmaceuticals Invited to Participate at Bio Partnering APAC 2017
2017-08-24
Asieris Pharmaceuticals Invited to Present at the 20th Annual Meeting of CSCO
2017-07-17
Asieris Pharmaceuticals Participated at 2017 BIO International Convention
2017-06-15
Welcome to Asieris Pharmaceuticals
2017-06-15
Asieris Pharmaceuticals to Participate at 2017 BIO International Convention
2017-05-31
Asieris Pharmaceuticals Presented at the 2017 ChinaBio® Partnering Forum
2017-03-30
Asieris announced first patient in APL-1202 pivotal trial
2017-03-22
Asieris to Present at 6th Annual Drug Repositioning, Repurposing and Rescue Conference
2017-02-26
Asieris announced initiation of APL-1202 pivotal clinical trial
2016-04-01
Asieris Pharmaceuticals is invited to present at the China Bio Partnership Forum 2016
2016-03-01
Scenes at the European Association of Urology (EAU) 2016 Congress
2015-12-02
Interim results of China Phase II Clinical Trial of APL-1202 accepted for presentation
2015-12-01
Asieris nominated as one of Jiangsu's "Innovation and Entrepreneurship Top 60" SMEs
2015-10-01
Asieris completed enrollment for its China Phase II Trial of APL-1202
2015-06-01
Asieris won "a Small- to Midium-Size Technological Enterprise (SME) in Jiangsu